Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

16 May 2019 --- Modifying gut microbes through diet can lessen inflammation in the brain of middle-aged male mice and could positively influence brain aging and function, a new... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

16 May 2019 --- Widespread interest in gut health platforms is growing and clinical research continues to place the microbiome at the heart of the health conversation. Probiotics... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 May 2019 --- Could a global logo or seal to communicate the quality of probiotic products could be on the cards, following the publication of an expert opinion in Frontiers in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 May 2019 --- A high-fat diet may contribute to the impairment of the gut barrier during pregnancy, which can lead to metabolic shifts and impede fetal development, according to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 May 2019 --- Researchers from King’s College London in the UK have secured US$1.8 million in funding to research the potential link between food additives and... Read More